Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells

Oncogene

Volumn 25, Issue 4, 2006, Pages 622-632

  Tsai, M H ^a   Chen, X ^a   Chandramouli, G V R ^a   Chen, Y ^b   Yan, H ^a   Zhao, S ^a   Keng, P ^c   Liber, H L ^d   Coleman, C N ^a   Mitchell, J B ^a   Chuang, E Y ^a,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Microarray; p53R2; Radiation; TK6

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53; PROTEIN P5R2; PROTEIN SUBUNIT; RIBONUCLEOTIDE REDUCTASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DNA MICROARRAY; DNA REPAIR; DOWN REGULATION; GAMMA RADIATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE INDUCTION; GENE LOCUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IONIZING RADIATION; KNOCKOUT GENE; LYMPHOBLASTOID CELL; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RADIATION DOSE; RNA ANALYSIS; TRANSCRIPTION REGULATION; UPREGULATION; WILD TYPE;

CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MUTATION; NF-KAPPA B; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 31544442476     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209082     Document Type: Article

References (48)

1. Amundson SA, Do KT, Shahab S, Bittner M, Meltzer P, Trent J et al. (2000). Radiat Res 154: 342-346.
2. Backlund MG, Trasti SL, Backlund DC, Cressman VL, Godfrey V, Koller BH. (2001). Cancer Res 61: 6577-6582.
3. Barcellos CK, Schetinger MR, Battastini AM, Silva LB, Dias RD, Sarkis JJ. (1994). Braz J Med Biol Res 27: 1111-1115.
4. Benjamin MB, Potter H, Yandell DW, Little JB. (1991). Proc Natl Acad Sci USA 88: 6652-6656.
5. Chen X, Shen B, Xia L, Khaletzkiy A, Chu D, Wong JY et al. (2002). Cancer Res 62: 1213-1221.
6. Chuang YY, Chen Q, Brown JP, Sedivy JM, Liber HL. (1999). Cancer Res 59: 3073-3076.
7. Chuang YY, Chen Y, Chandramouli GVR, Cook JA, Coffin D et al. (2002). Cancer Res 62: 6246-6254.
8. Coelho D, Fischer B, Holl V, Jung GM, Dufour P, Bergerat JP et al. (2002). Radiat Res 157: 446-452.
9. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. (2001). Nature 411: 494-498.
10. Elliott B, Jasin M. (2001). Mol Cell Biol 21: 2671-2682.
11. Evans E, Sugawara N, Haber JE, Alani E. (2000). Mol Cell 5: 789-799.
12. Ewan KB, Henshall-Powell RL, Ravani SA, Pajares MJ, Arteaga C, Warters R et al. (2002). Cancer Res 62: 5627-5631.
13. Fitch ME, Cross IV, Turner SJ, Adimoolam S, Lin CX, Williams KG et al. (2003). DNA Repair (Amsterdam) 2: 819-826.
14. Furth EE, Thilly WG, Penman BW, Liber HL, Rand WM. (1981). Anal Biochem 110: 1-8.
15. Geffrotin C, Tricaud Y, Crechet F, Castelli M, Lefaix JL, Vaiman M. (1998). Radiat Res 149: 472-481.
16. Gong B, Almasan A. (2000). Cancer Res 60: 5754-5760.
17. Guittet O, Hakansson P, Voevodskaya N, Fridd S, Graslund A, Arakawa H et al. (2001). J Biol Chem 276: 40647-40651.
18. Holbrook NJ, Liu Y, Fornace Jr AJ. (1996). EXS 77: 273-288.
19. Kawai H, Yamada Y, Tatsuka M, Niwa O, Yamamoto K, Suzuki F. (1999). Cancer Res 59: 6038-6041.
20. Kimura T, Takeda S, Sagiya Y, Gotoh M, Nakamura Y, Arakawa H. (2003). Nat Genet 34: 440-445.
21. Krikos A, Laherty CD, Dixit VM. (1992). J Biol Chem 267: 17971-17976.
22. Lakin ND, Jackson SP. (1999). Oncogene 18: 7644-7655.
23. Lin ZP, Belcourt MF, Cory JG, Sartorelli AC. (2004). J Biol Chem 279: 27030-27038.
24. Little JB, Nagasawa H, Keng PC, Yu Y, Li CY. (1995). J Biol Chem 270: 11033-11036.
25. Lozano G, Elledge SJ. (2000). Nature 404: 24-25.
26. Nakano K, Balint E, Ashcroft M, Vousden KH. (2000). Oncogene 19: 4283-4289.
27. Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL, Bedford JS. (2002). Cancer Res 62: 6400-6404.
28. Russo SM, Tepper JE, Baldwin Jr AS, Liu R, Adams J, Elliott P et al. (2001). Int J Radiat Oncol Biol Phys 50: 183-193.
29. Schena M, Shalon D, Davis RW, Brown PO. (1995). Science 270: 467-470.
30. Skopek TR, Liber HL, Penman BW, Thilly WG. (1978). Biochem Biophys Res Commun 84: 411-416.
31. Smith ML, Fornace Jr AJ. (1996). Mutat Res 340: 109-124.
32. Sugasawa K, Okamoto T, Shimizu Y, Masutani C, Iwai S, Hanaoka F. (2001). Genes Dev 15: 507-521.
33. Tan T, Chu G. (2002). Mol Cell Biol 22: 3247-3254.
34. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K et al. (2000). Nature 404: 42-49.
35. Teramoto T, Kiss A, Thorgeirsson SS. (1998). Biochem Biophys Res Commun 251: 56-60.
36. Wadgaonkar R, Phelps KM, Haque Z, Williams AJ, Silverman ES, Collins T. (1999). J Biol Chem 274: 1879-1882.
37. Wakefield LM, Roberts AB. (2002). Curr Opin Genet Dev 12: 22-29.
38. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS. (1998). Science 281: 1680-1683.
39. Webster GA, Perkins ND. (1999). Mol Cell Biol 19: 3485-3495.
40. Won KA, Schumacher RJ, Farr GW, Horwich AL, Reed SI. (1998). Mol Cell Biol 18: 7584-7589.
41. Xia F, Wang X, Wang YH, Tsang NM, Yandell DW, Kelsey KT et al. (1995). Cancer Res 55: 12-15.
42. Xue L, Zhou B, Liu X, Qiu W, Jin Z, Yen Y et al. (2003). Cancer Res 63: 980-986.
43. Yamaguchi T, Matsuda K, Sagiya Y, Iwadate M, Fujino MA, Nakamura Y et al. (2001). Cancer Res 61: 8256-8262.
44. Yang CR, Wilson-Van Patten C, Planchon SM, Wuerzberger-Davis SM, Davis TW, Cuthill S et al. (2000). FASEB J 14: 379-390.
45. Yang Q, Zhang R, Wang XW, Linke SP, Sengupta S, Hickson ID et al. (2004). Oncogene 23: 3749-3756.
46. Yu Y, Li CY, Little JB. (1997). Oncogene 14: 1661-1667.
47. Yu Y, Little JB. (1998). Cancer Res 58: 4277-4281.
48. Zhao W, Spitz DR, Oberley LW, Robbins ME. (2001). Cancer Res 61: 5537-5543.